The company in charge of the trial of an experimental drug that left one person dead and others possibly brain damaged has been found to be at fault, the French Health Ministry said.

A preliminary report found that the laboratory Biotrial failed to suspend the trial on Jan. 10 when one volunteer was hospitalized, and continued to inject other volunteers a day later. Four of those others were later hospitalized with brain disorders, Dow Jones Business News reports.

Biotrial will still be allowed to carry out drug trials, however, the health ministry said.

A total of 90 people were involved in read more >>>

Source : BusinessInsider.Com